Coexpression cluster:C532
From FANTOM5_SSTAR
Full id: C532_Mast_CD14_Eosinophils_seminal_ductus_Neutrophils_Smooth
Phase1 CAGE Peaks
Hg19::chr11:5705095..5705101,+ | p@chr11:5705095..5705101 + |
Hg19::chr17:32580142..32580147,+ | p@chr17:32580142..32580147 + |
Hg19::chr17:7747016..7747035,+ | p@chr17:7747016..7747035 + |
Hg19::chr17:7748946..7748974,+ | p1@AB383855 |
Hg19::chr17:7749478..7749496,+ | p@chr17:7749478..7749496 + |
Hg19::chr17:7750261..7750276,+ | p@chr17:7750261..7750276 + |
Hg19::chr17:7750417..7750437,+ | p10@KDM6B |
Hg19::chr1:186649543..186649563,- | p1@PTGS2 |
Hg19::chr1:31205338..31205351,- | p5@LAPTM5 |
Hg19::chr2:9695787..9695813,- | p3@ADAM17 |
Hg19::chr2:9695820..9695831,- | p5@ADAM17 |
Hg19::chr3:10291107..10291123,- | p1@BC009749 |
Hg19::chr5:148206163..148206201,+ | p1@ADRB2 |
Hg19::chr5:75839007..75839024,+ | p@chr5:75839007..75839024 + |
Hg19::chr6:144127704..144127730,+ | p1@ENST00000545614 |
Hg19::chr6:2889928..2889934,- | p@chr6:2889928..2889934 - |
Hg19::chrX:110924878..110924902,+ | p3@ALG13 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
No results for this coexpression
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0031347 | regulation of defense response | 0.000978689551586044 |
GO:0050727 | regulation of inflammatory response | 0.000978689551586044 |
GO:0048583 | regulation of response to stimulus | 0.00108557781968457 |
GO:0048589 | developmental growth | 0.00108557781968457 |
GO:0008217 | regulation of blood pressure | 0.00193438366969393 |
GO:0044459 | plasma membrane part | 0.00308260397451496 |
GO:0048636 | positive regulation of muscle development | 0.00308260397451496 |
GO:0048631 | regulation of skeletal muscle growth | 0.00308260397451496 |
GO:0004941 | beta2-adrenergic receptor activity | 0.00308260397451496 |
GO:0002032 | arrestin mediated desensitization of G-protein coupled receptor protein signaling pathway | 0.00308260397451496 |
GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity | 0.00308260397451496 |
GO:0048638 | regulation of developmental growth | 0.00308260397451496 |
GO:0019371 | cyclooxygenase pathway | 0.00308260397451496 |
GO:0051927 | negative regulation of calcium ion transport via voltage-gated calcium channel | 0.00308260397451496 |
GO:0048630 | skeletal muscle growth | 0.00308260397451496 |
GO:0048639 | positive regulation of developmental growth | 0.00308260397451496 |
GO:0048643 | positive regulation of skeletal muscle development | 0.00308260397451496 |
GO:0048633 | positive regulation of skeletal muscle growth | 0.00308260397451496 |
GO:0008015 | blood circulation | 0.00382645550491927 |
GO:0003013 | circulatory system process | 0.00382645550491927 |
GO:0002021 | response to dietary excess | 0.00382645550491927 |
GO:0048641 | regulation of skeletal muscle development | 0.00382645550491927 |
GO:0051930 | regulation of sensory perception of pain | 0.00382645550491927 |
GO:0051380 | norepinephrine binding | 0.00382645550491927 |
GO:0044246 | regulation of multicellular organismal metabolic process | 0.00382645550491927 |
GO:0002025 | norepinephrine-epinephrine vasodilation involved in regulation of systemic arterial blood pressure | 0.00382645550491927 |
GO:0044253 | positive regulation of multicellular organismal metabolic process | 0.00382645550491927 |
GO:0002024 | diet induced thermogenesis | 0.00382645550491927 |
GO:0051931 | regulation of sensory perception | 0.00382645550491927 |
GO:0005764 | lysosome | 0.0040595369483209 |
GO:0000323 | lytic vacuole | 0.0040595369483209 |
GO:0007171 | transmembrane receptor protein tyrosine kinase activation (dimerization) | 0.0040595369483209 |
GO:0004666 | prostaglandin-endoperoxide synthase activity | 0.0040595369483209 |
GO:0051926 | negative regulation of calcium ion transport | 0.0040595369483209 |
GO:0022401 | adaptation of signaling pathway | 0.0040595369483209 |
GO:0051925 | regulation of calcium ion transport via voltage-gated calcium channel | 0.0040595369483209 |
GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway | 0.0040595369483209 |
GO:0045932 | negative regulation of muscle contraction | 0.0040595369483209 |
GO:0048634 | regulation of muscle development | 0.0040595369483209 |
GO:0045986 | negative regulation of smooth muscle contraction | 0.0040595369483209 |
GO:0030501 | positive regulation of bone mineralization | 0.0040595369483209 |
GO:0005773 | vacuole | 0.00414753281572236 |
GO:0005737 | cytoplasm | 0.0041869488270513 |
GO:0005887 | integral to plasma membrane | 0.0041869488270513 |
GO:0031226 | intrinsic to plasma membrane | 0.0041869488270513 |
GO:0002028 | regulation of sodium ion transport | 0.0041869488270513 |
GO:0031649 | heat generation | 0.0041869488270513 |
GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway | 0.0041869488270513 |
GO:0043271 | negative regulation of ion transport | 0.0041869488270513 |
GO:0040015 | negative regulation of multicellular organism growth | 0.0041869488270513 |
GO:0045909 | positive regulation of vasodilation | 0.0041869488270513 |
GO:0019369 | arachidonic acid metabolic process | 0.0041869488270513 |
GO:0004939 | beta-adrenergic receptor activity | 0.0041869488270513 |
GO:0006954 | inflammatory response | 0.00454703326356174 |
GO:0005886 | plasma membrane | 0.00454703326356174 |
GO:0042640 | anagen | 0.00454703326356174 |
GO:0003085 | negative regulation of systemic arterial blood pressure | 0.00454703326356174 |
GO:0030259 | lipid glycosylation | 0.00454703326356174 |
GO:0045823 | positive regulation of heart contraction | 0.00454703326356174 |
GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine | 0.00454703326356174 |
GO:0050873 | brown fat cell differentiation | 0.00454703326356174 |
GO:0009888 | tissue development | 0.00479875604839804 |
GO:0008333 | endosome to lysosome transport | 0.0051203575259798 |
GO:0042312 | regulation of vasodilation | 0.0051203575259798 |
GO:0045778 | positive regulation of ossification | 0.0051203575259798 |
GO:0048820 | hair follicle maturation | 0.00570986645212989 |
GO:0046852 | positive regulation of bone remodeling | 0.00570986645212989 |
GO:0001659 | thermoregulation | 0.00570986645212989 |
GO:0009409 | response to cold | 0.00616266761559062 |
GO:0045776 | negative regulation of blood pressure | 0.00616266761559062 |
GO:0043410 | positive regulation of MAPKKK cascade | 0.00616266761559062 |
GO:0030279 | negative regulation of ossification | 0.00616266761559062 |
GO:0031348 | negative regulation of defense response | 0.00674522552025061 |
GO:0050728 | negative regulation of inflammatory response | 0.00674522552025061 |
GO:0001516 | prostaglandin biosynthetic process | 0.00728100014777047 |
GO:0046457 | prostanoid biosynthetic process | 0.00728100014777047 |
GO:0044444 | cytoplasmic part | 0.00728100014777047 |
GO:0009611 | response to wounding | 0.00729242213697446 |
GO:0030500 | regulation of bone mineralization | 0.00762495428690688 |
GO:0046851 | negative regulation of bone remodeling | 0.00762495428690688 |
GO:0051924 | regulation of calcium ion transport | 0.00811477290712111 |
GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal | 0.00811477290712111 |
GO:0042127 | regulation of cell proliferation | 0.00840369474061683 |
GO:0043393 | regulation of protein binding | 0.00848023396141709 |
GO:0045453 | bone resorption | 0.00848023396141709 |
GO:0007041 | lysosomal transport | 0.00902583568068267 |
GO:0043408 | regulation of MAPKKK cascade | 0.00934401488107085 |
GO:0004935 | adrenoceptor activity | 0.00934401488107085 |
GO:0019233 | sensory perception of pain | 0.00934401488107085 |
GO:0042383 | sarcolemma | 0.00964137233616056 |
GO:0003073 | regulation of systemic arterial blood pressure | 0.00964137233616056 |
GO:0045444 | fat cell differentiation | 0.00964137233616056 |
GO:0043269 | regulation of ion transport | 0.00991988063841718 |
GO:0006693 | prostaglandin metabolic process | 0.00991988063841718 |
GO:0006692 | prostanoid metabolic process | 0.00991988063841718 |
GO:0022404 | molting cycle process | 0.00997764542160359 |
GO:0001942 | hair follicle development | 0.00997764542160359 |
GO:0022405 | hair cycle process | 0.00997764542160359 |
GO:0042633 | hair cycle | 0.00997764542160359 |
GO:0042303 | molting cycle | 0.00997764542160359 |
GO:0042311 | vasodilation | 0.0101262875003404 |
GO:0048871 | multicellular organismal homeostasis | 0.0101262875003404 |
GO:0001894 | tissue homeostasis | 0.0101262875003404 |
GO:0030278 | regulation of ossification | 0.0101262875003404 |
GO:0006952 | defense response | 0.0102343075644826 |
GO:0030282 | bone mineralization | 0.0102638586560294 |
GO:0008144 | drug binding | 0.0102638586560294 |
GO:0006940 | regulation of smooth muscle contraction | 0.0102638586560294 |
GO:0040014 | regulation of multicellular organism growth | 0.0106775508915968 |
GO:0045927 | positive regulation of growth | 0.0110836621600943 |
GO:0009605 | response to external stimulus | 0.0112791690858978 |
GO:0044236 | multicellular organismal metabolic process | 0.0112791690858978 |
GO:0007190 | adenylate cyclase activation | 0.0112791690858978 |
GO:0046850 | regulation of bone remodeling | 0.0115641987395527 |
GO:0035264 | multicellular organism growth | 0.0115641987395527 |
GO:0051241 | negative regulation of multicellular organismal process | 0.0117116812339498 |
GO:0031644 | regulation of neurological process | 0.0117116812339498 |
GO:0007034 | vacuolar transport | 0.0117116812339498 |
GO:0051349 | positive regulation of lyase activity | 0.0117116812339498 |
GO:0042562 | hormone binding | 0.0117116812339498 |
GO:0045762 | positive regulation of adenylate cyclase activity | 0.0117116812339498 |
GO:0031281 | positive regulation of cyclase activity | 0.0117116812339498 |
GO:0016599 | caveolar membrane | 0.0117116812339498 |
GO:0005624 | membrane fraction | 0.0117867676968731 |
GO:0051098 | regulation of binding | 0.0124093172192136 |
GO:0005901 | caveola | 0.0126493606741491 |
GO:0009266 | response to temperature stimulus | 0.0126493606741491 |
GO:0051051 | negative regulation of transport | 0.0134145121932217 |
GO:0008283 | cell proliferation | 0.0134322515493759 |
GO:0046456 | icosanoid biosynthetic process | 0.0140378287728118 |
GO:0044255 | cellular lipid metabolic process | 0.0140378287728118 |
GO:0030424 | axon | 0.0142643319981669 |
GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway | 0.014988085910246 |
GO:0007189 | G-protein signaling, adenylate cyclase activating pathway | 0.0152885631121562 |
GO:0030425 | dendrite | 0.0155845405578184 |
GO:0006937 | regulation of muscle contraction | 0.0157602334413733 |
GO:0006939 | smooth muscle contraction | 0.0157602334413733 |
GO:0016197 | endosome transport | 0.0160333098829645 |
GO:0045761 | regulation of adenylate cyclase activity | 0.0160333098829645 |
GO:0006898 | receptor-mediated endocytosis | 0.0160333098829645 |
GO:0031279 | regulation of cyclase activity | 0.0160333098829645 |
GO:0035150 | regulation of tube size | 0.0160333098829645 |
GO:0050880 | regulation of blood vessel size | 0.0160333098829645 |
GO:0051339 | regulation of lyase activity | 0.0160333098829645 |
GO:0008016 | regulation of heart contraction | 0.0160333098829645 |
GO:0003018 | vascular process in circulatory system | 0.0163016636746157 |
GO:0043176 | amine binding | 0.0165663221137575 |
GO:0008375 | acetylglucosaminyltransferase activity | 0.0168273601100729 |
GO:0000267 | cell fraction | 0.0168923916912742 |
GO:0005783 | endoplasmic reticulum | 0.0169249719079181 |
GO:0003015 | heart process | 0.0171107214720378 |
GO:0060047 | heart contraction | 0.0171107214720378 |
GO:0006629 | lipid metabolic process | 0.0178474284798399 |
GO:0006690 | icosanoid metabolic process | 0.0178474284798399 |
GO:0007219 | Notch signaling pathway | 0.0178474284798399 |
GO:0065008 | regulation of biological quality | 0.0179568193605684 |
GO:0005765 | lysosomal membrane | 0.0179714160513918 |
GO:0030258 | lipid modification | 0.0182067513995556 |
GO:0021700 | developmental maturation | 0.0184390856486435 |
GO:0044424 | intracellular part | 0.0190150870897525 |
GO:0000187 | activation of MAPK activity | 0.0195797588639124 |
GO:0045926 | negative regulation of growth | 0.0208195291182241 |
GO:0005774 | vacuolar membrane | 0.0210297736412811 |
GO:0044437 | vacuolar part | 0.0215732462313401 |
GO:0043406 | positive regulation of MAP kinase activity | 0.0219124412563559 |
GO:0008227 | amine receptor activity | 0.0219124412563559 |
GO:0007519 | skeletal muscle development | 0.0219124412563559 |
GO:0004601 | peroxidase activity | 0.0219124412563559 |
GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor | 0.0219124412563559 |
GO:0051094 | positive regulation of developmental process | 0.0219780875876593 |
GO:0016324 | apical plasma membrane | 0.0219780875876593 |
GO:0043623 | cellular protein complex assembly | 0.0221703307430152 |
GO:0048523 | negative regulation of cellular process | 0.0228002364767809 |
GO:0048513 | organ development | 0.0228235872070181 |
GO:0006633 | fatty acid biosynthetic process | 0.0230480433826354 |
GO:0044425 | membrane part | 0.0234259517225252 |
GO:0048519 | negative regulation of biological process | 0.0240198556243217 |
GO:0051213 | dioxygenase activity | 0.0243764184368213 |
GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | 0.0243764184368213 |
GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | 0.0245463966944457 |
GO:0043005 | neuron projection | 0.0247144608941831 |
GO:0006950 | response to stress | 0.0249086842099581 |
GO:0016053 | organic acid biosynthetic process | 0.0249088586627779 |
GO:0046394 | carboxylic acid biosynthetic process | 0.0249088586627779 |
GO:0007188 | G-protein signaling, coupled to cAMP nucleotide second messenger | 0.0249364330664341 |
GO:0035239 | tube morphogenesis | 0.0249364330664341 |
GO:0045177 | apical part of cell | 0.025390642816825 |
GO:0019933 | cAMP-mediated signaling | 0.0254340205500935 |
GO:0014706 | striated muscle development | 0.0254340205500935 |
GO:0001503 | ossification | 0.0254340205500935 |
GO:0031214 | biomineral formation | 0.0254340205500935 |
GO:0043405 | regulation of MAP kinase activity | 0.0267312696456385 |
GO:0046849 | bone remodeling | 0.0274457487539909 |
GO:0032403 | protein complex binding | 0.0287179184066142 |
GO:0009968 | negative regulation of signal transduction | 0.0293936900008597 |
GO:0051240 | positive regulation of multicellular organismal process | 0.0293936900008597 |
GO:0048771 | tissue remodeling | 0.0293936900008597 |
GO:0043235 | receptor complex | 0.0304749358152983 |
GO:0051049 | regulation of transport | 0.0304749358152983 |
GO:0005622 | intracellular | 0.0306441670925344 |
GO:0007187 | G-protein signaling, coupled to cyclic nucleotide second messenger | 0.031919692513808 |
GO:0035295 | tube development | 0.031919692513808 |
GO:0006979 | response to oxidative stress | 0.0325711211180107 |
GO:0019935 | cyclic-nucleotide-mediated signaling | 0.0329477699037435 |
GO:0043231 | intracellular membrane-bound organelle | 0.0330240936432405 |
GO:0043227 | membrane-bound organelle | 0.0330240936432405 |
GO:0051179 | localization | 0.0339231025257245 |
GO:0003008 | system process | 0.0339231025257245 |
GO:0008544 | epidermis development | 0.0355591560521856 |
GO:0008194 | UDP-glycosyltransferase activity | 0.0360861562817729 |
GO:0048731 | system development | 0.0360861562817729 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 0.0360861562817729 |
GO:0045860 | positive regulation of protein kinase activity | 0.0364292355072501 |
GO:0033674 | positive regulation of kinase activity | 0.037023933710286 |
GO:0042165 | neurotransmitter binding | 0.0371054595085623 |
GO:0007398 | ectoderm development | 0.0371862005739715 |
GO:0051347 | positive regulation of transferase activity | 0.0372661677579912 |
GO:0000165 | MAPKKK cascade | 0.0378455823254122 |
GO:0009967 | positive regulation of signal transduction | 0.0384194404557652 |
GO:0042803 | protein homodimerization activity | 0.0394830124228228 |
GO:0005792 | microsome | 0.0402899138883853 |
GO:0003012 | muscle system process | 0.0404792835458063 |
GO:0006936 | muscle contraction | 0.0404792835458063 |
GO:0009628 | response to abiotic stimulus | 0.0404792835458063 |
GO:0042598 | vesicular fraction | 0.041266610787076 |
GO:0007517 | muscle development | 0.041805932616859 |
GO:0006814 | sodium ion transport | 0.0418612878776171 |
GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 0.042445128009613 |
GO:0043413 | biopolymer glycosylation | 0.042445128009613 |
GO:0016020 | membrane | 0.042774578519125 |
GO:0006816 | calcium ion transport | 0.0434886333429926 |
GO:0006631 | fatty acid metabolic process | 0.0451728489267306 |
GO:0005768 | endosome | 0.0454446066848645 |
GO:0010324 | membrane invagination | 0.0459808557273375 |
GO:0006897 | endocytosis | 0.0459808557273375 |
GO:0004222 | metalloendopeptidase activity | 0.0460157287143691 |
GO:0040008 | regulation of growth | 0.0465076206679614 |
GO:0001501 | skeletal development | 0.0481328068956095 |
GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 0.0481579159595137 |
GO:0048856 | anatomical structure development | 0.0485216815438028 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
hematopoietic system | 3.69e-44 | 98 |
blood island | 3.69e-44 | 98 |
bone marrow | 2.20e-42 | 76 |
hemolymphoid system | 1.81e-39 | 108 |
bone element | 6.18e-38 | 82 |
immune system | 5.53e-37 | 93 |
skeletal element | 3.00e-34 | 90 |
skeletal system | 5.35e-29 | 100 |
lateral plate mesoderm | 2.05e-22 | 203 |
mesoderm | 2.86e-14 | 315 |
mesoderm-derived structure | 2.86e-14 | 315 |
presumptive mesoderm | 2.86e-14 | 315 |
musculoskeletal system | 2.95e-11 | 167 |
connective tissue | 2.63e-09 | 371 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 0.644804 |
MA0004.1 | 0.221943 |
MA0006.1 | 0.112549 |
MA0007.1 | 0.599001 |
MA0009.1 | 0.621697 |
MA0014.1 | 0.707627 |
MA0017.1 | 0.137108 |
MA0019.1 | 0.340029 |
MA0024.1 | 0.525161 |
MA0025.1 | 0.747404 |
MA0027.1 | 2.20546 |
MA0028.1 | 1.26611 |
MA0029.1 | 0.542771 |
MA0030.1 | 0.532314 |
MA0031.1 | 0.474026 |
MA0038.1 | 0.302644 |
MA0040.1 | 0.548121 |
MA0041.1 | 0.236024 |
MA0042.1 | 0.211928 |
MA0043.1 | 0.621991 |
MA0046.1 | 0.611559 |
MA0048.1 | 0.0663643 |
MA0050.1 | 0.212584 |
MA0051.1 | 0.299199 |
MA0052.1 | 0.551663 |
MA0055.1 | 0.0307766 |
MA0056.1 | 0 |
MA0057.1 | 0.327175 |
MA0058.1 | 0.153757 |
MA0059.1 | 0.15289 |
MA0060.1 | 1.13861 |
MA0061.1 | 0.997605 |
MA0063.1 | 0 |
MA0066.1 | 0.302992 |
MA0067.1 | 0.924196 |
MA0068.1 | 3.14556 |
MA0069.1 | 0.607975 |
MA0070.1 | 0.597583 |
MA0071.1 | 0.27142 |
MA0072.1 | 0.593415 |
MA0073.1 | 13.249 |
MA0074.1 | 0.298586 |
MA0076.1 | 1.52428 |
MA0077.1 | 0.586275 |
MA0078.1 | 0.382364 |
MA0081.1 | 0.152999 |
MA0083.1 | 0.628701 |
MA0084.1 | 1.10674 |
MA0087.1 | 0.591148 |
MA0088.1 | 0.176197 |
MA0089.1 | 0 |
MA0090.1 | 0.174619 |
MA0091.1 | 0.223914 |
MA0092.1 | 0.570207 |
MA0093.1 | 0.114388 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 0.843378 |
MA0101.1 | 0.372085 |
MA0103.1 | 0.34743 |
MA0105.1 | 1.06659 |
MA0106.1 | 0.33677 |
MA0107.1 | 0.551112 |
MA0108.2 | 0.471286 |
MA0109.1 | 0 |
MA0111.1 | 1.03566 |
MA0113.1 | 0.350573 |
MA0114.1 | 0.25223 |
MA0115.1 | 0.850405 |
MA0116.1 | 0.264652 |
MA0117.1 | 0.656858 |
MA0119.1 | 0.438293 |
MA0122.1 | 0.681203 |
MA0124.1 | 0.810546 |
MA0125.1 | 1.73305 |
MA0130.1 | 0 |
MA0131.1 | 0.398042 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 0.650071 |
MA0136.1 | 0.30842 |
MA0139.1 | 0.934169 |
MA0140.1 | 1.36176 |
MA0141.1 | 0.462123 |
MA0142.1 | 0.445733 |
MA0143.1 | 0.350722 |
MA0144.1 | 0.231909 |
MA0145.1 | 1.49496 |
MA0146.1 | 0.0662401 |
MA0147.1 | 0.0784275 |
MA0148.1 | 0.240905 |
MA0149.1 | 0.261654 |
MA0062.2 | 0.97018 |
MA0035.2 | 0.740647 |
MA0039.2 | 0.750837 |
MA0138.2 | 0.38342 |
MA0002.2 | 1.07772 |
MA0137.2 | 0.126444 |
MA0104.2 | 0.188874 |
MA0047.2 | 0.326636 |
MA0112.2 | 0.08608 |
MA0065.2 | 0.376744 |
MA0150.1 | 0.508545 |
MA0151.1 | 0 |
MA0152.1 | 0.274535 |
MA0153.1 | 0.714423 |
MA0154.1 | 1.04686 |
MA0155.1 | 0.746636 |
MA0156.1 | 0.4018 |
MA0157.1 | 0.421609 |
MA0158.1 | 0 |
MA0159.1 | 0.96592 |
MA0160.1 | 0.252705 |
MA0161.1 | 0 |
MA0162.1 | 0.396029 |
MA0163.1 | 0.0944046 |
MA0164.1 | 0.361105 |
MA0080.2 | 0.366978 |
MA0018.2 | 0.337929 |
MA0099.2 | 0.27482 |
MA0079.2 | 0.0845756 |
MA0102.2 | 1.14323 |
MA0258.1 | 0.0605489 |
MA0259.1 | 0.28219 |
MA0442.1 | 0 |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
No analysis results for this cluster
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.